Residual contamination in antineoplastic drug packaging
- 19 January 2023
- journal article
- research article
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 29 (8), 1862-1867
- https://doi.org/10.1177/10781552231151693
Abstract
Introduction The handling of antineoplastic drugs should follow strict supervision and safety rules to minimize the occupational exposure risks to professionals involved. The external surface contamination of drug vials is recognized as a health risk. So, our goal was to determine if there is residual contamination on the vials and containers surface of the antineoplastic drugs doxorubicin (DOX) and cyclophosphamide (CP). Methods A cross-sectional study was conducted. Samples were collected using a uniform sampling procedure on the inner surfaces of the packages/boxes and the outer surfaces of the vials. The analyzes were executed by high-performance liquid chromatography/mass spectrometry (UHPLC-MS/MS). Results A total of 209 samples were analyzed, 66 of CP and 143 of DOX. CP levels were detected in nine samples (13.63%), three were below the lower limit of quantification (LLQ) and the other six had contamination levels ranging from 1.24 to 28.04 ng/filter. DOX levels were detected in 36 samples (25.17%), two were below the LLQ and the others had levels between 1.32 and 664.84 ng/filter. The majority of samples with residual contamination were in vials (80.0%), however, boxes also showed contamination. Conclusions The results revealed the presence of residual contamination in the vials and packages of CP and DOX drugs. Although the residues found in each sample are small, special care should be taken in the handling and disposal of the antineoplastic drugs. The use of personal protective equipment is fundamental while handling the vials and packaging of cytotoxic drugs.Keywords
Funding Information
- Fundo de Incentivo a Pesquisa (FIPE) da Diretoria de Pesquisa do Hospital de Clínicas de Porto Alegre
This publication has 27 references indexed in Scilit:
- Antineoplastic drug contamination in the urine of Canadian healthcare workersInternationales Archiv für Arbeitsmedizin, 2015
- Reproductive Health Risks Associated With Occupational Exposures to Antineoplastic Drugs in Health Care SettingsJournal of Occupational and Environmental Medicine, 2014
- Determination of the external contamination and cross-contamination by cytotoxic drugs on the surfaces of vials available on the Swiss marketJournal of Oncology Pharmacy Practice, 2013
- Wipe sampling procedure coupled to LC–MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfacesAnalytical and Bioanalytical Chemistry, 2011
- Surface contamination of antineoplastic drug vials: Comparison of unprotected and protected vialsAmerican Journal of Health-System Pharmacy, 2010
- Cyclophosphamide Contamination Observed on the External Surfaces of Drug Vials and the Efficacy of Cleaning on Vial ContaminationAnnals of Work Exposures and Health, 2008
- PrefaceJournal of Oncology Pharmacy Practice, 2007
- Simultaneous determination of gemcitabine, taxol, cyclophosphamide and ifosfamide in wipe samples by high‐performance liquid chromatography/tandem mass spectrometry: protocol of validation and uncertainty of measurementRapid Communications in Mass Spectrometry, 2007
- A new high‐performance liquid chromatographic/electrospray ionization tandem mass spectrometric method for the simultaneous determination of cyclophosphamide, methotrexate and 5‐fluorouracil as markers of surface contamination for occupational exposure monitoringJournal of Mass Spectrometry, 2005
- Development of an HPLC Method for Simultaneous Analysis of Five Antineoplastic AgentsApplied Occupational and Environmental Hygiene, 2003